Rare condition

Hypersensitivity pneumonitis

5

studies recruiting now

as of 7 Sept 2026

52

studies registered in total

as of 7 Sept 2026

4

countries with a recruiting site

as of 7 Sept 2026

6 Feb 2025

most recent study posted

among recruiting studies

Recruiting trials

RecruitingNCT06644144

P4O2 ILD Extension

Sponsor Amsterdam UMC, location VUmcWhere Netherlands (1 site)Studying No InterventionsUpdated 11 May 2026

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

Search all Hypersensitivity pneumonitis studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Keep watching

Get an email when a new Hypersensitivity pneumonitis study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Hypersensitivity pneumonitis

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Prednisolone (Cortalone)
Phase 2Pirfenidone (Esbriet)

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).